Since the discovery of the Rh blood group system in 1940, a greater understanding of
hemolytic disease of the fetus and newborn (HDFN) was gained. In the years thereafter …

A transfusion-requiring “late anemia” can complicate the management of neonates
convalescing from hemolytic disease of the fetus and newborn (HDFN). This anemia can …

Objetivo: Analisar a Doença hemolítica do recém-nascido (DHRN) e suas repercussões na
saúde materno-infantil. Revisão bibliográfica: A DHRN é uma condição na qual a gestante …

Objective: This study aimed to describe the historical experience of a single reference center
in Brazil with intrauterine transfusion (IUT) for Rhesus (Rh) alloimmunization, evaluating the …

新生儿溶血病(HDN) 是由于母体与新生儿血型不合, 母体产生抗体, 并通过胎盘输入胎儿体内,
造成胎儿红细胞破坏而发生的溶血, 严重威胁新生儿的生命健康. 降低血中胆红素水平 …

The primary indication for immunohematological testing in the prenatal patient is to detect
and identify maternal red cell antibodies. If there are antibodies that are expected to …

Advances in molecular techniques have been pivotal in improving our knowledge of the
structure and function of blood cell antigens, originally defined using serological techniques …

In transfusion therapy, unintentional mismatching of blood groups remains one of the most
common causes of serious and sometimes fatal adverse reactions. In addition, shortages of …

Objective: Hemolytic disease of the fetus and newborn (HDFN) can cause severe prenatal
and postnatal outcomes. The main objective of this study is to understand the clinical impact …

The authors report a case of neonatal haemolytic disease (HDN) attributable to maternal allo
immunization to a high frequency antigen present on paternal red blood cells which have …